Bio-Rad Laboratories, Inc. (BIO) Free Cash Flow
Bio-Rad Laboratories, Inc. (BIO) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $75.26M |
| 2017-12-31 | -$11.16M |
| 2018-12-31 | $166.94M |
| 2019-12-31 | $359.49M |
| 2020-12-31 | $476.48M |
| 2021-12-31 | $535.72M |
| 2022-12-31 | $80.10M |
| 2023-12-31 | $218.20M |
| 2024-12-31 | $289.60M |
| 2025-12-31 | $374.60M |
How BIO compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ALGN | Align Technology Inc. | $490.78M |
| ALNY | Alnylam Pharmaceuticals Inc. | $465.38M |
| PODD | Insulet Corporation | $349.90M |
| HAE | Haemonetics Corporation | $260.44M |
| MMSI | Merit Medical Systems Inc. | $212.53M |
These are five companies in the same sector as BIO with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Bio-Rad Laboratories, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("BIO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BIO | $387.70 | -0.57% | 0.21M |
| 3 | ||||
| 4 | ||||
| 5 |